Advancements in Osteosarcoma Therapy: Overcoming Chemotherapy Resistance and Exploring Novel Pharmacological Strategies
Osteosarcoma is recognized as the most prevalent primary bone malignancy, primarily affecting children and adolescents. It is characterized by its aggressive behavior and high metastatic potential, which often leads to poor patient outcomes. Despite advancements in surgical techniques and chemothera...
Saved in:
| Main Authors: | Mahmoud Zhra, Shahid Akhtar Akhund, Khalid S. Mohammad |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-04-01
|
| Series: | Pharmaceuticals |
| Subjects: | |
| Online Access: | https://www.mdpi.com/1424-8247/18/4/520 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Systemic strategies for osteosarcoma: advances and future directions
by: Vivek Kumar Morya, et al.
Published: (2025-07-01) -
Wnt/β-catenin signaling pathway: an attractive potential therapeutic target in osteosarcoma
by: Yi Ding, et al.
Published: (2025-02-01) -
Clinical Outcome Following Prolonged Neoadjuvant Chemotherapy and Delayed Surgery in Osteosarcoma Patients: An Evidence-based Clinical Review
by: Waluyo Sugito, et al.
Published: (2022-04-01) -
The presence of a fat layer after neoadjuvant chemotherapy as an indicator of prognosis in osteosarcoma
by: Junqi Huang, et al.
Published: (2025-04-01) -
NF-κB signaling pathway in osteosarcoma: from signaling networks to targeted therapy
by: Juandi Xue, et al.
Published: (2025-07-01)